Aug 20, 2021, 11:40 AM by

Researchers will be able to make faster and more accurate analysis of experiment data with a workflow powered by Qlucore Omics Explorer and MetaCore™, a Cortellis™ solution.

Aug 20, 2021, 11:40 AM by

Many cancer clinical research trials were put on hold during Covid – now Panthera Biopartners and Rutherford Health are working in partnership to accelerate oncology research in order to provide improved care for patients.

Aug 20, 2021, 11:40 AM by

Ashfield Engage, part of UDG Healthcare plc, announced that it has partnered with ADVANZ PHARMA to develop and deliver a pan-European talent acquisition programme for ADVANZ PHARMA’s specialty medicine division.

Aug 20, 2021, 11:40 AM by

StageZero Life Sciences, the company that created the first-ever test that simultaneously screens for multiple cancers from a single sample of blood, has acquired Care Oncology. Care Oncology has clinics in California, telehealth practices in all 50 states and provides treatments that complement and enhance the effect of standard-of-care cancer therapies. This acquisition expands StageZero’s clinical offerings, including access to a robust network of oncologists and physicians across the U.S.

Aug 20, 2021, 11:40 AM by

Partek® Flow® bioinformatics software to be integrated into Agilent Alissa Clinical Informatics Platform to deliver a complete end-to-end analysis.

Aug 20, 2021, 11:40 AM by

Aug 20, 2021, 11:40 AM by

Pluto, a Denver-based biotech software startup, launched it's secure, collaborative life sciences platform to be the digital lab space for life sciences teams of all sizes, anywhere in the world. The Pluto platform leverages technology developed at Harvard's Wyss Institute and simplifies secure, collaborative data sharing and bioinformatics analysis for academic, biotech, and pharmaceutical organizations, enabling them to make discoveries faster and more efficiently.

Aug 20, 2021, 11:40 AM by

Aug 20, 2021, 01:00 AM by User Not Found

Bio-IT World | In the biopharmaceutical industry, there’s no shortage of data—the issue organizations more often face is how to capture data in ways that derive insight from it. Rather than stitching together a patchwork of data from disparate systems after the fact, more emphasis should be placed on capturing data in context, right at the point of execution.

Aug 17, 2021, 01:00 AM by User Not Found

Bio-IT World | A novel organ-on-a-chip model of ovarian cancer has been used to showcase the sinister activities of tumors, including use of circulating platelets to fuel their growth and undermine treatment with chemotherapeutic drugs. The model also demonstrated the potential of an anti-platelet drug, currently in clinical trials for a different condition: to fight back.

Aug 13, 2021, 01:00 AM by User Not Found

Bio-IT World | Network theory holds that everything is connected—including if the “nodes” are human cells, genomes, proteomes, or transcriptomes. It is “pure, algorithm-run precision math,” and it could be an entirely new approach to big data science that could erase the declining odds that a drug entering clinical studies will exit a winner.

Aug 11, 2021, 05:24 AM by User Not Found

Bio-IT World | A team of researchers in Barcelona have gathered bioactivity information for a million molecules using deep machine-learning computational models and a database of experimental results. Both the experimental results and the machine learning tool are available to the community at bioactivitysignatures.org.

Aug 10, 2021, 01:00 AM by User Not Found

Bio-IT World | Until recently, Ross Mitchell served as the inaugural AI Officer at the Moffitt Cancer Center in Tampa, Florida. Now he’s offering consulting expertise borne of a long career applying AI to healthcare and health systems.

Aug 5, 2021, 05:26 AM by User Not Found

Bio-IT World | Deep Genomics nets cash for AI-designed RNA therapeutics, Strata advances personalized minimal residual disease (MRD) assays, Frontier Medicines goes after the proteome, and more.

Aug 4, 2021, 01:00 AM by User Not Found

Bio-IT World | The Bio-IT World Conference and Expo will be happening both in-person and online this year—giving our community even more options for learning and connection. We’ve been busy marking our schedules and making our plans. Here are our best tips for making the most both the in person and online options.

Aug 3, 2021, 01:00 AM by User Not Found

Bio-IT World | Kings College London uses NVIDIA’s Cambridge-1 supercomputer to build synthetic brain images, Singapore researcher detect SARS-CoV-2 in wastewater, American Heart Association Issues statement on genomic research diversity, and biobank acquisitions. Plus new products from 10x Genomics, Paradigm4, Thermo Fisher, Cresset.

Jul 29, 2021, 01:00 AM by User Not Found

Bio-IT World | Russia plans to introduce special digital genetic passports that will contain genome sequencing of each citizen of the country—the data could be further used for the formation of genetic profiles and identification of susceptibility to diseases, according to recent statements made by some senior officials of the Russian federal government and analysts.

Jul 28, 2021, 01:00 AM by User Not Found

Bio-IT World | Bio-IT World has announced the 2021 Innovative Practices Awards winners. Grand prize awards were granted to Duke Cancer Institute with University of California, San Francisco, Micronoma, and Regeneron Pharmaceuticals. Pure Storage and the Folding@home project received honorable mention recognition. All four groups will be presenting their projects at the 2021 Bio-IT World Conference & Expo in Boston in September.

Jul 27, 2021, 01:00 AM by User Not Found

Bio-IT World | The National Institutes of Health has made a five-year, nearly $80 million commitment to the establishment of a Mendelian Genomics Research Consortium of five clinical laboratories and one data coordinating center. The Consortium will build on previous National Human Genome Research Institute (NHGRI) work to develop new methods for identifying the genetic causes of single-gene diseases.

Jul 23, 2021, 01:00 AM by User Not Found

Bio-IT World | The board members of both Sema4 and CM Life Sciences voted this week to approve the special purpose acquisition company. The resulting combined company, Sema4 Holdings Corp, will commence trading of its shares of common stock and warrants on the Nasdaq Global Select Market under the ticker symbols "SMFR" and “SMFRW” today or Monday.